New options for testing and treating some of the most common sexually transmitted diseases are becoming available ...
Money Talks News on MSN
Skip the colonoscopy: New study shows simple stool test just as effective
Scientists have discovered that collecting stool samples at home is as life-saving as invasive colonoscopy procedures.
Money Talks News on MSN
This at-home test detects cancer as effectively as a colonoscopy
This indicates that the test is as effective as colonoscopy in reducing colorectal cancer mortality in screening [programs],” ...
Consumers simply prick a finger, place a drop of blood on a sample card, sealed into an envelope (provided) and mail it to ...
When it comes to monitoring your pet's health or diagnosing medical conditions, a fecal test for dogs is a common starting ...
There is a great deal of excitement around microbiome research as it confirms, and debunks, long-held beliefs. Investigators have shown, for example, that proton-pump inhibitors can alter the ...
Chicago, IL–based healthcare technology giant Abbott Laboratories will acquire Exact Sciences for $23 billion. Exact’s flagship product, Cologuard, is an at-home, stool-based test approved by the FDA ...
Exact Sciences' new launches and big ambitions in the cancer market make it an exciting long-term pick. Roku turned a profit for the first time in years, showing that the streaming platform's strategy ...
I’ve dealt with chronic indigestion, painful burps, reflux, and bloating for the past 15 years. In 2010, I underwent a range of diagnostic tests—a colonoscopy, an endoscopy, a gastric emptying test, ...
Exact Sciences' most important product is driving solid revenue growth. It has launched several others that could help boost sales and jolt the stock. The company's long-term prospects look attractive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results